| CAS: | 701232-20-4 | ||||
| 分子式: | C22H26N4O3 | ||||
| 分子量: | 394.47 | ||||
| 英文名称: |
| ||||
| 用途: | T863 是选择性,有口服活性的二酰基甘油酰基转移酶1 (DGAT1) 抑制剂,能结合DGAT1的酰基辅酶A结合位点,抑制三酰甘油在细胞内的合成。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||
| T877741 | MACKLIN | T863 | ≥98% | 699元/5mg; 999元/10mg; 1599元/25mg; 4999元/100mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||
储存:2-8℃ | |||||||||||||||||||||||||||||||||||||||||||
| SML0539 | Sigma-Aldrich | T863 | ≥98% (HPLC) | 1714.02元/5 MG; 5250.73元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||
产品说明 应用 T863 has been used as a diglyceride acyltransferase (DGAT1) inhibitor:
包装 5, 25 mg in glass bottle 生化/生理作用 T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. T863 causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||
| 434662 | Fluorochem | 2-((1R,4R)-4-(4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl)cyclohexyl)acetic acid | 95% | 12716元/250mg; 31746元/1g; | 咨询 | ||||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||||